Welcome to our dedicated page for Aimfinity Investment I SEC filings (Ticker: AIMAU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Aimfinity Investment Corp. I (AIMAU) provide detailed insight into its operations as a special purpose acquisition company (SPAC) and its proposed business combination with Docter Inc. As a blank check company incorporated in the Cayman Islands, Aimfinity Investment Corp. I reports material events and transaction milestones through current reports on Form 8-K, annual reports on Form 10-K, and registration statements filed with the U.S. Securities and Exchange Commission.
On this page, you can review Form 8-K filings that describe the Agreement and Plan of Merger among Aimfinity Investment Corp. I, Docter Inc., and affiliated merger subsidiaries. These filings outline the structure of the reincorporation merger and acquisition merger, the role of the purchaser entity referred to as PubCo, and the expectation that PubCo will be renamed Inkwater Holding Inc. upon consummation of the business combination. Related 8-Ks also disclose shareholder approval of the transaction at an extraordinary general meeting and provide unaudited pro forma condensed combined financial information for the combined company.
Filings further document the company’s monthly extensions of the deadline to complete its business combination. Form 8-K reports explain unsecured promissory notes issued to a sponsor designee, the amounts deposited into the trust account as monthly extension payments, and the terms under which these notes may be exchanged into PubCo ordinary shares upon closing of the transaction. These documents also summarize shareholder redemption activity and the scenarios considered in pro forma financial statements.
Through Stock Titan, users can access these SEC filings with AI-powered summaries that highlight key terms, structural features, and financial implications. Real-time updates from EDGAR make it easier to track new 8-Ks, 10-Ks and related registration statements, while AI-generated explanations help clarify complex topics such as reverse recapitalization accounting, pro forma ownership tables, and the conditions required to complete the business combination. This page also provides a gateway to monitor any insider-related disclosures and subsequent amendments that may affect the SPAC’s capital structure or transaction timeline.
Aimfinity Investment Corp. I entered into an unsecured promissory note for
Under the note and an earlier exchange agreement, any unpaid balance will automatically convert into PubCo ordinary shares at a conversion price of
Aimfinity Investment Corp I (AIMAU) filed an 8-K furnishing updated unaudited pro forma condensed combined financials for its pending merger with Docter Inc.
- Shareholders approved the Business Combination at the 27 Mar 2025 extraordinary general meeting.
- 1,072,957 Class A shares were redeemed; the pro forma schedules now reflect the actual cash outflow and reduced public float.
- Updates incorporate conversion of extension and working-capital loans, Docter promissory notes, discharge agreements and a 12-month burn-rate estimate.
- The deal will be accounted for as a reverse recapitalization; Docter holders will control the post-close vehicle, renamed “Inkwater Holding”.
- Base scenario assumes no warrant exercises and no earn-out shares, providing a clean view of initial ownership and capital structure.
The filing supplies investors with revised balance sheet, ownership table and key transaction accounting adjustments, but excludes synergy forecasts.
FAQ
What is the current stock price of Aimfinity Investment I (AIMAU)?
